Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Yamashita Health Care Holdings EV-to-EBITDA?
Yamashita Health Care HoldingsTSE:9265 68 EV-to-EBITDA is 4.25 as of Sep. 16, 2026, which is 45% above its 10-year median of 2.94. GuruFocus rates TSE:9265 with a GF Score™ of 68/100 and a GF Value™ of 円2,968.81 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 101 Medical Distribution companies, Yamashita Health Care Holdings ranks better than 82.18% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Yamashita Health Care Holdings's enterprise value is 円5,079 Mil.
Yamashita Health Care Holdings's EBITDA for the trailing twelve months (TTM) ended in May. 2026 was 円1,195 Mil. Therefore, Yamashita Health Care Holdings's EV-to-EBITDA for today is 4.25.
The historical rank and industry rank for Yamashita Health Care Holdings's EV-to-EBITDA or its related term are showing as below:
TSE:9265'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 0.15 Med: 2.94 Max: 22.93
Current: 4.25
During the past 9 years, the highest EV-to-EBITDA of Yamashita Health Care Holdings was 22.93. The lowest was 0.15. And the median was 2.94.
TSE:9265's EV-to-EBITDA is ranked better than 82.18% of 101
companies
in the Medical Distribution industry
Industry Median: 8.43
vs TSE:9265: 4.25
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Yamashita Health Care Holdings (TSE:9265) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Yamashita Health Care Holdings's PE Ratio (TTM) for today is calculated as:
Yamashita Health Care Holdings's share price for today is 円3620.00.
Yamashita Health Care Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円259.273.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:9265 vs MCK, COR, CAH: EV-to-EBITDA Comparison
For the Medical Distribution subindustry, Yamashita Health Care Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yamashita Health Care Holdings EV-to-EBITDA vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Yamashita Health Care Holdings's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Yamashita Health Care Holdings's EV-to-EBITDA falls into.
Yamashita Health Care Holdings's current Enterprise Value is 円5,079 Mil.
Yamashita Health Care Holdings's EBITDA for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,195 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yamashita Health Care Holdings (TSE:9265) has a EV-to-EBITDA of 4.25 as of Sep. 16, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Yamashita Health Care Holdings. This is 45% above median its historical median of 2.94. Over the past decade, Yamashita Health Care Holdings' EV-to-EBITDA has ranged from 0.15 to 22.93. According to the industry distribution chart, Yamashita Health Care Holdings ranks #18 out of 101 companies in the Medical Distribution industry, placing it in the top 17.8%.
Is Yamashita Health Care Holdings' EV-to-EBITDA too high?
Yamashita Health Care Holdings' current EV-to-EBITDA of 4.25 is 45% above median its 10-year median of 2.94. Over the past 10 years, this metric has ranged from a low of 0.15 to a high of 22.93. The Medical Distribution industry median EV-to-EBITDA is 8.43. Yamashita Health Care Holdings' value of 4.25 is 49.6% below this industry median. Based on the distribution chart, Yamashita Health Care Holdings ranks #18 out of 101 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Yamashita Health Care Holdings has a GF Score™ of 68/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Yamashita Health Care Holdings' EV-to-EBITDA compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Yamashita Health Care Holdings ranks #18 out of 101 companies for EV-to-EBITDA. This places Yamashita Health Care Holdings in the top 18% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 8.43. Yamashita Health Care Holdings' value of 4.25 is 49.6% below this benchmark. Historically, Yamashita Health Care Holdings' own EV-to-EBITDA has ranged from 0.15 to 22.93 over the past decade. While the company's 10-year median is 2.94 vs. the industry median of 8.43, Yamashita Health Care Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Distribution company?
The median EV-to-EBITDA among Medical Distribution companies is 8.43, based on 101 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yamashita Health Care Holdings's current EV-to-EBITDA of 4.25 is 49.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Yamashita Health Care Holdings. For the Medical Distribution industry, the median EV-to-EBITDA is 8.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yamashita Health Care Holdings's current EV-to-EBITDA is 4.25, which is 45% above median its own 10-year median of 2.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yamashita Health Care Holdings stock overvalued right now?
Based on GuruFocus' analysis, Yamashita Health Care Holdings (TSE:9265) is currently considered Modestly Overvalued. The stock's GF Value™ is 円2,968.81, compared to a current price of 円3,620.00 — trading 21.9% above its estimated fair value. The current EV-to-EBITDA is 4.25, which is 45% above median its 10-year median of 2.94 and 49.6% below the Medical Distribution industry median of 8.43. Yamashita Health Care Holdings' overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Yamashita Health Care Holdings (TSE:9265), the current EV-to-EBITDA is 4.25 as of Sep. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Yamashita Health Care Holdings (TSE:9265) Overvalued in 2026?
Based on GuruFocus' analysis, Yamashita Health Care Holdings stock appears to be overvalued.
The current stock price of 円3,620.00 is trading 21.9% above its estimated GF Value™ of 円2,968.81.
GuruFocus considers Yamashita Health Care Holdings to be Modestly Overvalued.
Key valuation signals for TSE:9265:
EV-to-EBITDA: 4.25 (45% above median its 10-year median of 2.94)
GF Value™: 円2,968.81 vs. price of 円3,620.00 (21.9% above fair value)
Industry Position: 49.6% below the Medical Distribution median (#18 of 101)
No single metric tells the full story. See the TSE:9265 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Yamashita Health Care Holdings Inc is a Japan-based medical equipment wholesale company that sells medical equipment for medical institutions within the Kyushu area. The company is also engaged in the manufacture, sale, leasing, and rental of optical instruments, physicochemical instruments, analytical instruments, measuring instruments, health equipment, exercise equipment, nursing care equipment, animal medical equipment, and veterinary drugs.
68GF Score
Get the complete analysis for TSE:9265
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9265 has been successfully added to your 
